Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-04-14
1990-03-27
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514289, 546 39, 546 44, 546 45, 546 46, 546 74, A61K 31485, C07D48902, C07D22128
Patent
active
049121146
ABSTRACT:
Compounds of formula I ##STR1## wherein X and Y each denotes hydrogen or together denote -0-,
REFERENCES:
patent: 3488354 (1970-01-01), Brown et al.
patent: 4148794 (1979-04-01), Lewis et al.
patent: 4208523 (1980-06-01), Michne et al.
patent: 4217353 (1980-08-01), Smith Jr.
patent: 4255579 (1981-03-01), Michne
Belleau, Chemical Abstracts, vol. 98(9):65101b (1982).
Fleischacker, et al., Monatshefte fur Chemie, vol. 108, pp. 1441-1451 (1977).
Fleischacker, et al., Chem. Ber., vol. 112, pp. 2539-2551 (1979).
Bentley, et al., J. Am. Chem. Soc., vol. 89(13), pp. 3293-3303 (1967).
Lewis, et al., J. Med. Chem., vol. 16(1), pp. 9-12 (1973).
Lewis, et al., Chemical Abstracts, vol. 68:69164c (1968).
Bentley, et al., J. Org. Chem., vol. 23, pp. 1720-1725 (1958).
Besser, et al., Opioid Modulation of Endocrine Function, pp. 99-109 (1984).
Delitala, et al., Opioid Modulation of Endocrine Function, pp. 65-79 (1984).
Ferin, M., Opioid Modulation of Endocrine Function, pp. 185-189 (1984).
Meites, et al., Life Science, vol. 24, pp. 1325-1336 (1979).
Morley, J. E., Endocrine Reviews, vol. 8, No. 3, 256-287 (1987).
Atkinson, R. L., Jour. of Clin. Endocr. and Metab., vol. 55, No. 1, pp. 196-198 (1982).
Morley, et al., Science, vol. 209, pp. 1259-1261 (1980).
Thompson, et al., Life Sciences, vol. 31, pp. 847-852 (1982).
Holaday, et al., Nature, vol. 275, pp. 450 and 451 (1978).
Peters, et al., The Lancet, pp. 529-532 (1981).
Kosten, et al., Life Sciences, vol. 39, pp. 55-59 (1986).
Bain, et al., Life Sciences, vol. 40, pp. 1119-1125 (1987).
Kiianmaa, et al., Psychopharmacology, vol. 79, pp. 291-294 (1983).
Hynes, et al., Life Sciences, vol. 33, pp. 2331-2337 (1983).
Reisberg, et al., New England Jour. of Medicine, vol. 308, pp. 721 and 722 (1983).
Kaiya, et al., Life Sciences, vol. 33, pp. 1039-1043 (1983).
Banks, et al., The Lancet, pp. 1227-1230 (1983).
Derwent Abstract No. 3819c.
Derwent Abstract No. 38194C.
Derwent Abstract No. 56852C.
Derwent Abstract No. 70322E.
Borovian Joseph J.
Honor Robert S.
Rivers Diane G.
Sandoz Ltd.
Shah Mukund J.
LandOfFree
Morphinan derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Morphinan derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Morphinan derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1651274